Brain Imaging, Volume 164, the latest release in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to neuroimaging in aging and neurodegenerative disease. Topics covered in this new release include FTD spectrum, Cerebrovascular disease, HIV, Huntington’s Disease, Development of brain PET imaging agents, and Disclosure of imaging biomarker results.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter 1 AD - p. xiii 8. 1a: Brain MRI findings related to Alzheimer's disease in older African American adults - p. xiii 9. 1b: Magnetoencephalography applied to the study of Alzheimer's disease - p. 23 10. 1ci: AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention - p. 61 11. 1cii: AD molecular: Imaging tau aggregates with positron emissions tomography - p. 106 12. 1ciii: AD molecular: Molecular imaging of Alzheimer's disease: PET imaging of neurotransmitter systems - p. 138 13. Chapter 2: PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies - p. 165 14. Chapter 3: FTD spectrum: Neuroimaging across the FTD spectrum - p. 185 15. Chapter 4: Cerebrovascular disease: Neuroimaging of cerebral small vessel disease - p. 223 16. Chapter 5 HIV - p. 255 17. 5a: Is treated HIV infection still toxic to the brain? - p. 255 18. 5b: Aberrant brain dynamics in neuroHIV: Evidence from magnetoencephalographic (MEG) imaging - p. 284 19. Chapter 6: Huntington's disease: Brain imaging in Huntington's disease - p. 320 20. Chapter 7: Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease - p. 369 21. Chapter 8: Disclosure of amyloid PET scan results: A systematic review - p. 399 22. Index - p. 415
Brain Imaging, Volume 164, the latest release in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to neuroimaging in aging and neurodegenerative disease. Topics covered in this new release include FTD spectrum, Cerebrovascular disease, HIV, Huntington’s Disease, Development of brain PET imaging agents, and Disclosure of imaging biomarker results.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. ix 6. Preface - p. xiii 7. Chapter 1 AD - p. xiii 8. 1a: Brain MRI findings related to Alzheimer's disease in older African American adults - p. xiii 9. 1b: Magnetoencephalography applied to the study of Alzheimer's disease - p. 23 10. 1ci: AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention - p. 61 11. 1cii: AD molecular: Imaging tau aggregates with positron emissions tomography - p. 106 12. 1ciii: AD molecular: Molecular imaging of Alzheimer's disease: PET imaging of neurotransmitter systems - p. 138 13. Chapter 2: PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies - p. 165 14. Chapter 3: FTD spectrum: Neuroimaging across the FTD spectrum - p. 185 15. Chapter 4: Cerebrovascular disease: Neuroimaging of cerebral small vessel disease - p. 223 16. Chapter 5 HIV - p. 255 17. 5a: Is treated HIV infection still toxic to the brain? - p. 255 18. 5b: Aberrant brain dynamics in neuroHIV: Evidence from magnetoencephalographic (MEG) imaging - p. 284 19. Chapter 6: Huntington's disease: Brain imaging in Huntington's disease - p. 320 20. Chapter 7: Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease - p. 369 21. Chapter 8: Disclosure of amyloid PET scan results: A systematic review - p. 399 22. Index - p. 415
